Home LiteratureArticle Details
PMID: 6401163 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.

Cancer research ·Vol. 43 ·No. 1 ·1983-01-00 ·Pages 125-32

Frost P, Kerbel RS, Bauer E, Tartamella-Biondo R, Cefalu W

Abstract

暂无摘要

MeSH Terms
Adenocarcinoma/drug therapy,immunology Animals Ethyl Methanesulfonate/therapeutic use Mammary Neoplasms, Experimental/drug therapy,immunology Mast-Cell Sarcoma/drug therapy Methylnitronitrosoguanidine/therapeutic use Mice Mice, Inbred BALB C Mice, Inbred DBA Mutagens/therapeutic use Ouabain/pharmacology Thioguanine/pharmacology
Chemicals
Mutagens Methylnitronitrosoguanidine Ouabain Ethyl Methanesulfonate Thioguanine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Frost P
Kerbel R S
Bauer E
Tartamella-Biondo R
Cefalu W
Article Info
Journal
Cancer research
Abbr.
Cancer Res
ISSN
0008-5472
Published
1983-01-00
Pages
125-32
Language
English
Region
United States
NLM ID
2984705R
Subset
IM
Grants
NCI NIH HHS · CA 28060 · United States
External Links
PubMed source View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2